Back

The present: antibodies siRNAs

30 August 2026 (17:42 - 17:54)
Organised by: Logo
Congress Presentation Part of: Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing Risk Factors and Prevention ESC Professional Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Professor Kausik K Ray

Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)

4 More presentations in this session

Presentation thumbnail
The discovery of PCSK9
Professor C. Boileau (Paris, FR)
Slides Video
Presentation thumbnail
Oral PCSK9 inhibitors
Doctor C. Ballantyne (Houston, US)
Slides Video
Presentation thumbnail
The future: gene editing
Professor A. Zeiher (Frankfurt, DE)
Slides Video
Presentation thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing - discussion
Video

Access the full session

Session thumbnail
Present and the future of PCSK9 inhibition in cardiovascular prevention: from antibodies to gene editing
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:42 CET
You may be interested in
thumbnail
Congress Presentation
Targeting the PCSK9 pathway: where do novel therapies fit in?
26 August 2022
thumbnail
Congress Presentation
Action mechanism of siRNAs
28 August 2026
thumbnail
Congress Presentation
Efficacy and safety of SYH2053 in patients with primary hypercholesterolemia or mixed dyslipidemia: a phase II, multicenter, randomized, double-blind, placebo- and active-controlled trial
31 August 2026
thumbnail
Congress Presentation
Monoclonal antibodies, gene silencing, and gene editing (CRISPR) therapies for the treatment of hyperlipidaemia
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources